NasdaqCM - Nasdaq Real Time Price USD
BioNexus Gene Lab Corp. (BGLC)
At close: November 5 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,866.2360
-1,301.5950
551.8220
9.1610
552.6800
Investing Cash Flow
-267.3020
-382.5760
-450.4980
-490.5740
1,319.9900
Financing Cash Flow
5,956.3330
5,754.3220
108.1680
-28.2220
-4.9470
End Cash Position
5,581.4750
5,929.3360
2,118.8640
2,123.9190
2,787.6920
Income Tax Paid Supplemental Data
63.1100
66.9730
170.4470
226.7700
143.4960
Interest Paid Supplemental Data
17.5830
13.9290
12.4790
12.9730
11.3130
Capital Expenditure
-158.7180
-149.3980
-54.1710
-3.1620
-421.6210
Issuance of Capital Stock
--
--
150.0000
--
--
Repayment of Debt
-38.9970
--
-34.0380
-26.3020
-4.9470
Free Cash Flow
-2,024.9540
-1,450.9930
497.6510
5.9990
131.0590
12/31/2020 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BON Bon Natural Life Limited
1.4100
+3.68%
ALFFF Alfa S.A.B. de C.V.
0.6700
0.00%
DLNDY D&L Industries, Inc.
2.6500
0.00%
IOFNF Iofina plc
0.2600
0.00%
CRKN Crown Electrokinetics Corp.
1.0200
+6.38%
FPLSF 5N Plus Inc.
5.12
0.00%
FDXTF FendX Technologies Inc.
0.1216
0.00%
BIOF Blue Biofuels, Inc.
0.1240
+4.20%
ECVT Ecovyst Inc.
7.78
+1.97%
IOSP Innospec Inc.
111.13
+2.04%